[1] F. Aqil and I. Ahmad, “Rapid and Accurate Species―Specific Detection of Phytophthora Infestans throu- gh Analysis of Its Regions in Its rDNA,” Journal of Microbiology and Biotechnology, Vol. 19, No. 6, 2000, pp. 653-657.
[2] A. W. Bauer, W. M. M. Kirby, J. C. Sherris and M. Turch, “Antibiotic Susceptibility Testing by a Standardized Single Disk Method,” American Journal of Clinical Pathology, Vol. 45, No. 5, 1998, pp. 493-496.
[3] O. Bruno, A. Ranise, F. Bonadavalli, P. Schenone, M. D’Amico, W. Felipplli, A. Filippelli and F. Rossi, “3,5- Diphenyl-1H-Pyrazole Derivatives. XI. N-Aryl-5(3)- Phenyl-4-(3,5-Diphenyl-1-Pyrazolyl)-3(5)-Pyrazole Ami- nes, 5-Substituted 4,5-Dihydro-3-Phenyl-4-(3,5-Diphenyl -1-Pyrazolyl)-1H-Pyrazoles and 2,6-Disubstituted 1,6-Di- hydro-4-Phenyl-5-(3,5-Diphenyl-1-Pyrazolyl)Pyrimidines with Antipyretic, Anti-Inflammatory and Other Activi- ties,” Farmaco, Vol. 48, No. 4, 1998, pp. 949-966
[4] J. R. Dimmock, S. K. Raghavan, et al., “Antileukemic Evaluation of Some Mannich Bases Derived from 2- Arylidene-1,3-Diketones,” European Journal of Medicinal Chemistry, Vol. 18, No. 4, 1998, pp. 248-254.
[5] H. R. Eisenhauer and K. P. Link,“ Studies on 4-Hydroxy- Coumarins. XIII. The Mechanism for the Reaction of 4-Hydroxycoumarin with Aliphatic Acid Chlorides,” Journal of the American Chemical Society, Vol. 75, No. 9, 1953, pp. 2044-2050. doi:10.1021/ja01105a006
[6] A. A. El-Barbary, A. I. Khodair, E. B. Pederson and C. Nielsen, “S-Glucosylated Hydantoins as New Antiviral agents,” Journal of Medicinal Chemistry, Vol. 37, No. 1, 1994, pp. 73-77. doi:10.1021/jm00027a009
[7] E. S. M. El-khawass and A. E. Bistawroos, “Synthesis and Biological Activity of Heterocycles from Chalcone,” Medicinal Chemistry Research, Vol. 17, No. 2-7, 2008, pp. 318-325
[8] H. I. El-Subbagh, S. M. Abu-Zaid, M. A. Mahran, F. A. Badaria, Al-Obaid,” Synthesis and Biological Evaluation of Certain α,β-Unsaturated Ketones and Their Corresponding Fused Pyridines as Antiviral and Cytotoxic Agents,” Journal of Medicinal Chemistry, Vol. 43, No. 15, 2000, pp. 2915-2921. doi:10.1021/jm000038m
[9] E. O. Nuzum, P. J. Rosenthal and J. H. Mckerrow, “In Vitro Antimalarial Activity of Chalcones and Their Derivatives,” Journal of Medicinal Chemistry, Vol. 38, No. 26, 1995, pp. 5031-5037. doi:10.1021/jm00026a010
[10] A. Nayak and A. S. Mittra, “4,4-Bis-5-Pyrazolones and Their 4,4-Unsaturated Products for Possible Use as Fungicides,” Journal of the Indian Chemical Society, Vol. 57, 1980, pp. 643-649
[11] N. Marquez, R. Sancho, L. M. Bedoya, J. Alcamy, J. L. Lopez-Perez, A. S. Feliciano, B. L. Fiebich and E. Munoz, “Mesuol, a Natural Occurring 4-Phenylcoumarin, Inhibits HIV-1 Replication by Targeting the NF-κB Pathway,” Antiviral Research, Vol. 66, No. 2-3, 2005, pp. 137-143. doi:10.1016/j.antiviral.2005.02.006
[12] C. Spino, M. Dodier and S. Sotheeswaran, “Anti-HIV Coumarins from Calophyllum Seed Oil,” Bioorganic & Medicinal Chemistry Letters, Vol. 8, No. 24, 1998, pp. 3475-3481. doi:10.1016/S0960-894X(98)00628-3
[13] S. Thaisrivongs, K. D. Watenpaugh, W. J. Howe, et al., “Structure-Based Design of Novel HIV Protease In- hibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic Inhibi- tors,” Journal of Medicinal Chemistry, Vol. 38, No. 18, 1995, pp. 3624-3630. doi:10.1021/jm00018a023
[14] D. Yu, M. Suzuki, L. Xie, S. L. Morris-Natschke and K. H. Lee, “Recent Progress in the Development of Coumarin Derivatives as Potent Anti-HIV Agents,” Medicinal Research Reviews, Vol. 23, No. 3, 2003, pp. 322-328. doi:10.1002/med.10034
[15] J. W. Erickson and S. K. Burt, “Structural Mechanisms of HIV Drug Resistance,” Annual Review of Pharmacology and Toxicology, Vol. 36, 1996, pp. 545-571. doi:10.1146/annurev.pa.36.040196.002553
[16] I. Kostova, S. Raleva, P. Genova and R. Argirova, “Structural Features of Antitumor Titanium Agents and Related Compounds,” Bioinorganic Chemistry and Appli- cations, Vol. 3, No. 3-4, 2005, pp. 317-329. doi:10.1155/BCA.2005.317
[17] A. J. Vlietinck, T. de Bruyne, S. Apers and L. A. Pieters, “Plant-Derived Leading Compounds for Chemotherapy of Human Immunodeficiency Virus (HIV) Infection”, Medicinal Chemistry Research, Vol. 64, 1998, pp. 97- 102.
[18] J. B. Harborne and T. J. Mabry, “Title of This Paper,” Chem Abstr, Vol. 119, No. *, pp. 180774-******.
[19] K. Kostka, “Chromone Derivatives. VI. Reaction of Phenylhydrazine with Chromone and x-Formyl-o-Hydro- Xyacetophenone,” Polish Journal of Chemistry, Vol. 47, 1973, pp. 305-313
[20] E. O. Nuzum, P. J. Rosenthal and J. H. Mckerrow, “In Vitro Antimalarial Activity of Chalcones and Their Derivatives,” Journal of Medicinal Chemistry, Vol. 38, No. 26, 1995, pp. 5031-5037. doi:10.1021/jm00026a010
[21] A. Nayak and A. S. Mittra “4,4-Bis-5-Pyrazolones and Their 4,4-Unsaturated Products for Possible Use as Fungicides,” Journal of the Indian Chemical Society, Vol. 57, 1980, pp. 643-649
[22] O. Nerya, R. Musa, S. Khatib, S. Tamir, Vaya, “Chalcones as Potent Tyrosinase Inhibitors: The Effect of Hydroxyl Positions and Numbers,” Phytochemistry, Vol. 65, No. 10, 2004, pp. 1389-1395. doi:10.1016/j.phytochem.2004.04.016
[23] Z. N. Siddiqui, G. Khuwaja and M. Asad, “Synthesis of Novel Heterocycles from 3-(3-Alkyl-5-Mercapto-1,2,4- Triazolyliminomethyl) Chromones,” Heterocyclic Commun, Vol. 12, No. 6, 2006, pp. 443-448
[24] L. Santana, E. Uriarte, L. via Dalla and O. Gia, “A New Benzoangelicin with Strong Photobiological Activity,” Bioorganic & Medicinal Chemistry Letters, Vol. 10, No. 6, 2000, pp. 135-137. doi:10.1016/S0960-894X(99)00640-X
[25] R. H. Wiley and C. H. Jarboe, “Synthesis of Pyrazolines by the Reactions of α,β-enones with Diazomethane and Hydrazines,” Chemistry of Heterocyclic Compounds, Vol. 33, No. 6, 1997, pp. 647-659, doi:10.1007/BF02291794
[26] K. C. Fylaktakidou, D. J. Hadjipavlou-Litina, K. E. Litinas and D. N. Nicolaides, “Natural and Syntheticcoumarin Derivatives with Anti-Inflammatory and Antioxidant Activity,” Current Pharmaceutical Design, Vol. 10, No. 6, 2004, pp. 3813-3833
[27] S. Kirkiachiarian, R. Bakhchinian, H. Chidiak, M. Mazmanian and C. Planche, “Two New Flavonoids and Other Constituents in Licorice Root; Their Relative Astringency and Radical Scavenging Effects,” Annales Pharmaceutiques Fran?aises, Vol. 57, No. 5, 1999, pp. 251-259.
[28] J. R. Soares, T. C. P. Dins, A. P. Cunha and L. M. Ameida, “Antioxidant Activity of Some Extracts of Thymus Zygis,” Free Radical Research, Vol. 26, No. 5, 1997, pp. 469-476. doi:10.3109/10715769709084484